TY - JOUR AU - Tsai, J. Y. AU - Iannitti, D. A. AU - Safran, H. PY - 2003 DA - 2003// TI - Combined Modality Therapy for pancreatic cancer JO - Seminars in Oncology VL - 30 UR - https://doi.org/10.1016/S0093-7754(03)00273-2 DO - 10.1016/S0093-7754(03)00273-2 ID - Tsai2003 ER - TY - JOUR AU - Neoptolemos, J. P. AU - Cunningham, D. AU - Friess, H. PY - 2003 DA - 2003// TI - Adjuvant therapy in pancreatic cancer: historical and current perspectives JO - Ann Oncol VL - 14 UR - https://doi.org/10.1093/annonc/mdg207 DO - 10.1093/annonc/mdg207 ID - Neoptolemos2003 ER - TY - JOUR AU - Cantore, M. AU - Fiorentini, G. AU - Luppi, G. PY - 2003 DA - 2003// TI - Randomised trial of gemcitabine versus flec regimen given intra-arterially for patients with unresectable pancreatic cancer JO - J Exp Clin Cancer Res VL - 22 ID - Cantore2003 ER - TY - JOUR AU - Zalatnai, A. AU - Molnár, J. PY - 2007 DA - 2007// TI - Molecular background of chemoresistance in pancreatic cancer JO - In Vivo VL - 21 ID - Zalatnai2007 ER - TY - JOUR AU - Siddik, Z. H. PY - 2003 DA - 2003// TI - Cisplatin: mode of cytotoxic action and molecular basis of resistance JO - Oncogene VL - 22 UR - https://doi.org/10.1038/sj.onc.1206933 DO - 10.1038/sj.onc.1206933 ID - Siddik2003 ER - TY - JOUR AU - Itoh, N. AU - Semba, S. AU - Ito, M. AU - Takeda, H. AU - Kawata, S. AU - Yamakawa, M. PY - 2002 DA - 2002// TI - Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma JO - Cancer VL - 94 UR - https://doi.org/10.1002/cncr.10591 DO - 10.1002/cncr.10591 ID - Itoh2002 ER - TY - JOUR AU - Izuishi, K. AU - Kato, K. AU - Ogura, T. AU - Kinoshita, T. AU - Esumi, H. PY - 2000 DA - 2000// TI - Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy JO - Cancer Res VL - 60 ID - Izuishi2000 ER - TY - JOUR AU - Brognard, J. AU - Clark, A. S. AU - Ni, Y. AU - Dennis, P. A. PY - 2001 DA - 2001// TI - Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation JO - Cancer Res VL - 61 ID - Brognard2001 ER - TY - JOUR AU - Yang, X. AU - Fraser, M. AU - Moll, U. M. AU - Basak, A. AU - Tsang, B. K. PY - 2006 DA - 2006// TI - Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-0425 DO - 10.1158/0008-5472.CAN-05-0425 ID - Yang2006 ER - TY - JOUR AU - Kim, S. H. AU - Juhnn, Y. S. AU - Song, Y. S. PY - 2007 DA - 2007// TI - Akt Involvement in Paclitaxel Chemoresistance of Human Ovarian Cancer Cells JO - Ann N Y Acad Sci VL - 1095 UR - https://doi.org/10.1196/annals.1397.012 DO - 10.1196/annals.1397.012 ID - Kim2007 ER - TY - JOUR AU - Xing, H. AU - Weng, D. AU - Chen, G. PY - 2008 DA - 2008// TI - Activation of fibronectin/PI-3K/Akt2 leads to chemoresistance to docetaxel by regulating survivin protein expression in ovarian and breast cancer cells JO - Cancer Lett VL - 261 UR - https://doi.org/10.1016/j.canlet.2007.11.022 DO - 10.1016/j.canlet.2007.11.022 ID - Xing2008 ER - TY - JOUR AU - Ohta, T. AU - Ohmichi, M. AU - Hayasaka, T. PY - 2006 DA - 2006// TI - Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models JO - Endocrinology VL - 147 UR - https://doi.org/10.1210/en.2005-1450 DO - 10.1210/en.2005-1450 ID - Ohta2006 ER - TY - JOUR AU - Hayakawa, J. AU - Ohmichi, M. AU - Kurachi, H. PY - 2000 DA - 2000// TI - Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin JO - Cancer Res VL - 60 ID - Hayakawa2000 ER - TY - JOUR AU - Ning, S. AU - Chen, Z. AU - Dirks, A. PY - 2007 DA - 2007// TI - Targeting integrins and PI3K/Akt-mediated signal transduction pathways enhances radiation-induced anti-angiogenesis JO - Radiat Res VL - 168 UR - https://doi.org/10.1667/RR0829.1 DO - 10.1667/RR0829.1 ID - Ning2007 ER - TY - JOUR AU - D'Incalci, M. AU - Colombo, T. AU - Ubezio, P. PY - 2003 DA - 2003// TI - The combination of yondelis and cisplatin is synergistic against human tumor xenografts JO - Eur J Cancer VL - 39 UR - https://doi.org/10.1016/S0959-8049(03)00490-8 DO - 10.1016/S0959-8049(03)00490-8 ID - D'Incalci2003 ER - TY - JOUR AU - Tomita, Y. AU - Morooka, T. AU - Hoshida, Y. PY - 2006 DA - 2006// TI - Prognostic significance of activated AKT expression in soft-tissue sarcoma JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1732 DO - 10.1158/1078-0432.CCR-05-1732 ID - Tomita2006 ER - TY - JOUR AU - Cinti, C. AU - Vindigni, C. AU - Zamparelli, A. PY - 2008 DA - 2008// TI - Activated Akt as an indicator of prognosis in gastric cancer JO - Virchows Arch VL - 453 UR - https://doi.org/10.1007/s00428-008-0676-8 DO - 10.1007/s00428-008-0676-8 ID - Cinti2008 ER - TY - JOUR AU - Chadha, K. S. AU - Khoury, T. AU - Yu, J. PY - 2006 DA - 2006// TI - Activated Akt and Erk expression and survival after surgery in pancreatic carcinoma JO - Ann Surg Oncol VL - 13 UR - https://doi.org/10.1245/ASO.2006.07.011 DO - 10.1245/ASO.2006.07.011 ID - Chadha2006 ER - TY - JOUR AU - Park, S. S. AU - Kim, S. W. PY - 2007 DA - 2007// TI - Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression JO - Oncol Rep VL - 18 ID - Park2007 ER - TY - JOUR AU - Han, Z. AU - Hong, L. AU - Han, Y. PY - 2007 DA - 2007// TI - Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax JO - J Exp Clin Cancer Res VL - 26 ID - Han2007 ER - TY - JOUR AU - Han, Z. AU - Hong, L. AU - Wu, K. PY - 2006 DA - 2006// TI - Reversal of multidrug resistance of gastric cancer cells by downregulation of Akt1 with Akt1 siRNA JO - J Exp Clin Cancer Res VL - 25 ID - Han2006 ER - TY - JOUR AU - Clark, A. S. AU - West, K. AU - Streicher, S. AU - Dennis, P. A. PY - 2002 DA - 2002// TI - Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells JO - Mol Cancer Ther VL - 1 ID - Clark2002 ER - TY - JOUR AU - Chong, Z. Z. AU - Maiese, K. PY - 2004 DA - 2004// TI - Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system JO - Histol Histopathol VL - 19 ID - Chong2004 ER - TY - JOUR AU - Wang, G. AU - Reed, E. AU - Li, Q. Q. PY - 2004 DA - 2004// TI - Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer JO - Oncol Rep VL - 12 ID - Wang2004 ER - TY - JOUR AU - Brozovic, A. AU - Osmak, M. PY - 2007 DA - 2007// TI - Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance JO - Cancer Lett VL - 251 UR - https://doi.org/10.1016/j.canlet.2006.10.007 DO - 10.1016/j.canlet.2006.10.007 ID - Brozovic2007 ER - TY - JOUR AU - Kayaselcuk, F. AU - Nursal, T. Z. AU - Polat, A. PY - 2004 DA - 2004// TI - Expression of survivin, bcl-2, P53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a) JO - J Exp Clin Cancer Res VL - 23 ID - Kayaselcuk2004 ER - TY - JOUR AU - Hu, L. AU - Zaloudek, C. AU - Mills, G. B. AU - Gray, J. AU - Jaffe, R. B. PY - 2000 DA - 2000// TI - In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002) JO - Clin Cancer Res VL - 6 ID - Hu2000 ER -